Old Web
English
Sign In
Acemap
>
Paper
>
O52 Switching to Biosimilar Infliximab: Real-World Data from the Southampton Biologic Therapies Review Service
O52 Switching to Biosimilar Infliximab: Real-World Data from the Southampton Biologic Therapies Review Service
2016
Christopher R. Holroyd
Lucy Parker
Sarah Bennett
Jalaa Zarroug
Caron Underhill
Brian Davidson
Ray D. Armstrong
Nicholas C. Harvey
Elaine M. Dennison
Cyrus Cooper
Christopher J. Edwards
Keywords:
Biosimilar Pharmaceuticals
Biosimilar
Alternative medicine
Infliximab
Medicine
Pharmacology
Physical therapy
biologic therapies
real world data
Intensive care medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
10
Citations
NaN
KQI
[]